ARTANE Side Effects

6975322-0 | Confusional State
on Feb 26, 2009 Male patient from UNITED STATES , 70 years of age, was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state. Artane dosage: .

6975310-4 | Headache, Sluggishness
Patient was taking Artane (View Usage). Patient had the following side effects: headache (What is headache?), sluggishness on Feb 26, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Artane dosage: .

6769115-7 | Anhidrosis, Hyperthermia, Temperature Regulation Disorder
Adverse event was reported on Jun 07, 2010 by a Male patient taking Artane (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 71 years of age, After Artane was administered, patient had the following side effects: anhidrosis, hyperthermia, temperature regulation disorder. During the same period patient was treated with PERGOLIDE MESYLATE (View Pergolide Mesylate Review and Pergolide Mesylate Label ), CARBIDOPA LEVODOPA (View Carbidopa-levodopa Review and Carbidopa-levodopa Label ). Patient was hospitalized.

6730976-9 | Akinesia, Anhidrosis, Constipation, Dysphagia, Haemangioma Of Liver, Hyperreflexia, Hyperthermia, Hypothalamo-pituitary Disorder, Muscle Rigidity
on May 06, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: akinesia, anhidrosis, constipation (What is constipation?), dysphagia, haemangioma of liver, hyperreflexia, hyperthermia, hypothalamo-pituitary disorder, muscle rigidity. Artane dosage: . During the same period patient was treated with PERGOLIDE MESYLATE (View Pergolide Mesylate Review and Pergolide Mesylate Label ), CARBIDOPA LEVODOPA (View Carbidopa-levodopa Review and Carbidopa-levodopa Label ). Patient was hospitalized.


6404751-9 | Accidental Overdose, Altered State Of Consciousness
on Oct 05, 2009 Female patient from JAPAN , child 1 years of age, was treated with Artane (View Usage). Patient had the following side effects: accidental overdose, altered state of consciousness. Artane dosage: .

6390027-5 | Delirium, Dry Mouth, Hallucination, Mydriasis, Overdose
Patient was taking Artane (View Usage). After Artane was administered, patient had the following side effects: delirium, dry mouth, hallucination, mydriasis, overdose on Sep 25, 2009 from ARGENTINA Additional patient health information: Male patient , 21 years of age, was diagnosed with parkinsonism and. Artane dosage: 10 Tablets (overdose Amount 50 Mg). During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

6380239-9 | C-reactive Protein Decreased, Intentional Self-injury, Neuroleptic Malignant Syndrome
Adverse event was reported on Sep 17, 2009 by a Male patient taking Artane (View Usage) (Dosage: ) was diagnosed with parkinsonism, depression (What is depression?) and. Location: JAPAN , 48 years of age, Patient experienced the following unwanted or unexpected effects: c-reactive protein decreased, intentional self-injury, neuroleptic malignant syndrome. During the same period patient was treated with TOLEDOMIN (View Toledomin Review and Toledomin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HALCION (View Halcion Review and Halcion Label ), IMPROMEN (View Impromen Review and Impromen Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6290710-6 | Disturbance In Attention, Oscillopsia, Vision Blurred
on Jul 28, 2009 Male patient from UNITED STATES , 22 years of age, weighting 200.0 lb, was treated with Artane (View Usage). Patient had the following side effects: disturbance in attention, oscillopsia, vision blurred. Artane dosage: 5 Mg Down To 1 Mg 3 Times A Day Po.

6198904-5 | Anaphylactic Reaction, Apparent Life Threatening Event, Throat Tightness
on May 20, 2009 Female patient from UNITED STATES , 50 years of age, weighting 120.0 lb, was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: anaphylactic reaction, apparent life threatening event, throat tightness. Artane dosage: . Patient was hospitalized and became disabled.

6021793-6 | Dementia
Patient was taking Artane (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?) on Dec 22, 2008 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Artane dosage: . During the same period patient was treated with CARBIDOPA (View Carbidopa Review and Carbidopa Label ), NITOROL (View Nitorol Review and Nitorol Label ), SIGMART (View Sigmart Review and Sigmart Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), AMLODIN (View Amlodin Review and Amlodin Label ).

6016131-9 | Dementia
Adverse event was reported on Dec 17, 2008 by a Male patient taking Artane (View Usage) (Dosage: ) . Location: JAPAN , 80 years of age, Patient had the following side effects: dementia (What is dementia?).

5519306-8 | Neuroleptic Malignant Syndrome
on Nov 06, 2007 Female patient from JAPAN , 51 years of age, was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: neuroleptic malignant syndrome. Artane dosage: ^1 % Pow^.

5518955-0 | Hypertensive Crisis, No Therapeutic Response, Onychomadesis, Stevens-johnson Syndrome, Streptococcal Infection
on Nov 14, 2007 Male patient from UNITED STATES , 39 years of age, weighting 190.0 lb, was diagnosed with loss of consciousness, prophylaxis and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis, no therapeutic response, onychomadesis, stevens-johnson syndrome, streptococcal infection (What is streptococcal infection?). Artane dosage: . Patient was hospitalized and became disabled.

5368271-5 | Neuroleptic Malignant Syndrome, Renal Failure, Rhabdomyolysis
Patient was taking Artane (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, renal failure, rhabdomyolysis on Jun 14, 2007 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with schizophrenia and. Artane dosage: . During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), CLONIDINE HCL (View Clonidine Hcl Review and Clonidine Hcl Label ). Patient was hospitalized.

5296450-4 | Stevens-johnson Syndrome
Adverse event was reported on Apr 03, 2007 by a Male patient taking Artane (View Usage) (Dosage: 15 Mg) . Location: TUNISIA , 26 years of age, After Artane was administered, patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with LIBRIUM (View Librium Review and Librium Label ), ELAVIL (View Elavil Review and Elavil Label ), LARGACTIL (View Largactil Review and Largactil Label ), CANNABIS (View Cannabis Review and Cannabis Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

5287664-8 | Blood Creatine Phosphokinase Increased
on Mar 28, 2007 Female patient from JAPAN , 81 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Artane dosage: . During the same period patient was treated with PARLODEL (View Parlodel Review and Parlodel Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

5247562-2 | Aggression, Cervical Vertebral Fracture, Fall, Homicidal Ideation, Paranoia, Rapid Eye Movements Sleep Abnormal, Respiratory Arrest, Sleep Disorder
on Feb 16, 2007 Male patient from AUSTRALIA , 99 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Artane (View Usage). Patient had the following side effects: aggression, cervical vertebral fracture, fall (What is fall?), homicidal ideation, paranoia, rapid eye movements sleep abnormal, respiratory arrest, sleep disorder (What is sleep disorder?). Artane dosage: . During the same period patient was treated with COMTAN (View Comtan Review and Comtan Label ), CABASER (2 Mg, Unk) (View Cabaser Review and Cabaser Label ), ZESTRIL (View Zestril Review and Zestril Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), SINEMET (View Sinemet Review and Sinemet Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ). Patient was hospitalized.

5237364-5 | Torticollis
Patient was taking Artane (View Usage). After Artane was administered, patient had the following side effects: torticollis on Feb 01, 2007 from JAPAN Additional patient health information: Female patient , weighting 112.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Artane dosage: . During the same period patient was treated with SYMMETREL (View Symmetrel Review and Symmetrel Label ), PARLODEL (View Parlodel Review and Parlodel Label ). Patient was hospitalized.

5206011-0 | Confusional State, Hallucination, Hallucination, Auditory
Adverse event was reported on Oct 25, 2006 by a Male patient taking Artane (View Usage) (Dosage: 2 Ng 3x Per 1 Day; Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, hallucination, hallucination, auditory. During the same period patient was treated with MODOPAR (BENSERAZIDE HYDROCHLORIDE/LEVODOPA) (View Modopar (benserazide Hydrochloride/levodopa) Review and Modopar (benserazide Hydrochloride/levodopa) Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ).

5170508-2 | Confusional State, Hallucination, Hallucination, Auditory
on Nov 22, 2006 Male patient from JAPAN , 71 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Artane (View Usage). Patient had the following side effects: confusional state, hallucination, hallucination, auditory. Artane dosage: 2 Mg 1x Per 1 Day; Oral.

5165124-2 | Cognitive Disorder, Condition Aggravated, Delirium, Depressed Level Of Consciousness, Gait Disturbance, Hallucination, Auditory, Hallucination, Visual, Hypertension, Mental Disorder
on Nov 09, 2006 Female patient from JAPAN , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: cognitive disorder, condition aggravated, delirium, depressed level of consciousness, gait disturbance, hallucination, auditory, hallucination, visual, hypertension, mental disorder. Artane dosage: 2 Mg 1x Per 1 Day Oral. During the same period patient was treated with LEVODOPA (200 Mg 1x Per 1 Day Oral) (View Levodopa Review and Levodopa Label ), SELEGILINE HYDROCHLORIDE (See Image) (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ). Patient was hospitalized.

5126022-3 | Hepatic Fibrosis
Patient was taking Artane (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic fibrosis on Sep 27, 2006 from JAPAN Additional patient health information: Female patient , 38 years of age, . Artane dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), VEGETAMIN (1 Df) (View Vegetamin Review and Vegetamin Label ), DOGMATYL (Unk) (View Dogmatyl Review and Dogmatyl Label ), ZOLPIDEM TARTRATE (Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), SOLANAX (View Solanax Review and Solanax Label ).

5098593-7 | Abnormal Behaviour, Alanine Aminotransferase Decreased, Aplastic Anaemia, Aspartate Aminotransferase Decreased, Basophil Count Decreased, Blood Glucose Increased, Blood Sodium Decreased, Blood Urea Decreased, Bone Marrow Disorder
Adverse event was reported on May 18, 2006 by a Male patient taking Artane (View Usage) (Dosage: 3 Mg/day) was diagnosed with parkinsonism, gastritis, psychotic disorder (What is psychotic disorder?) and. Location: JAPAN , 27 years of age, weighting 165.3 lb, Patient had the following side effects: abnormal behaviour, alanine aminotransferase decreased, aplastic anaemia, aspartate aminotransferase decreased, basophil count decreased, blood glucose increased, blood sodium decreased, blood urea decreased, bone marrow disorder. During the same period patient was treated with GASMOTIN (1.5 G/day) (View Gasmotin Review and Gasmotin Label ), TEGRETOL (300 Mg/day) (View Tegretol Review and Tegretol Label ), RISPERDAL (3 Mg/day) (View Risperdal Review and Risperdal Label ), HYSERENIN (400 Mg/day) (View Hyserenin Review and Hyserenin Label ). Patient was hospitalized.

5087240-6 | Abnormal Behaviour, Cerebral Atrophy, Cerebral Ventricle Dilatation, Delirium, Delusion, Depressed Level Of Consciousness, Disorientation, Hallucination, Memory Impairment
on Aug 07, 2006 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?) and was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: abnormal behaviour, cerebral atrophy, cerebral ventricle dilatation, delirium, delusion, depressed level of consciousness, disorientation, hallucination, memory impairment. Artane dosage: See Image. During the same period patient was treated with BIPERIDEN (BIPERIDEN, ) (See Image) (View Biperiden (biperiden, ) Review and Biperiden (biperiden, ) Label ), DIAZEPAM (See Image) (View Diazepam Review and Diazepam Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), SULPIRIDE (SULPIRIDE) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ). Patient was hospitalized.

5081986-1 | Oral Intake Reduced, Tardive Dyskinesia
on Jul 31, 2006 Male patient from JAPAN , 53 years of age, was diagnosed with dyskinesia and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: oral intake reduced, tardive dyskinesia. Artane dosage: 3 Mg. Patient was hospitalized.

5080713-1 | Abnormal Behaviour, Amnesia, Delirium, Delusion, Depression, Disorientation, Hallucination, Visual, Senile Dementia
Patient was taking Artane (View Usage). Patient had the following side effects: abnormal behaviour, amnesia, delirium, delusion, depression (What is depression?), disorientation, hallucination, visual, senile dementia on Jul 27, 2006 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with depression (What is depression?) and. Artane dosage: 2 + 4mg 1x Per 1 Day Oral - See Image. During the same period patient was treated with BIPERIDEN (BIPERIDEN, ) (2 + 1 Mg 1x Per 1 Day Oral- See Image) (View Biperiden (biperiden, ) Review and Biperiden (biperiden, ) Label ), DIAZEPAM (3.5 + 7 Mg 1x Per 1 Day Oral - See Image) (View Diazepam Review and Diazepam Label ), SULPIRIDE (SULPIRIDE) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), DONEPEZIL HCL (5mg 1xper 1 Day) (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5038282-8 | Abnormal Behaviour, Aplastic Anaemia, Coombs Direct Test Positive, Dizziness, Haematocrit Decreased, Haemoglobin Decreased, Malaise
Adverse event was reported on May 18, 2006 by a Male patient taking Artane (View Usage) (Dosage: 3 Mg/day) was diagnosed with parkinsonism, gastritis, psychotic disorder (What is psychotic disorder?) and. Location: JAPAN , 27 years of age, weighting 165.3 lb, After Artane was administered, patient had the following side effects: abnormal behaviour, aplastic anaemia, coombs direct test positive, dizziness (What is dizziness?), haematocrit decreased, haemoglobin decreased, malaise. During the same period patient was treated with GASMOTIN (1.5 G/day) (View Gasmotin Review and Gasmotin Label ), TEGRETOL (300 Mg/day) (View Tegretol Review and Tegretol Label ), RISPERDAL (3 Mg/day) (View Risperdal Review and Risperdal Label ), HYSERENIN (400 Mg/day) (View Hyserenin Review and Hyserenin Label ). Patient was hospitalized.

4994188-1 | Depressed Level Of Consciousness, Diabetic Ketoacidosis, Hyperamylasaemia, Hypertension, Neuroleptic Malignant Syndrome, Obesity, Osteoporosis, Renal Failure Acute, Shock
on Apr 20, 2006 Female patient from JAPAN , 59 years of age, was diagnosed with parkinsonism, schizophrenia and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, diabetic ketoacidosis, hyperamylasaemia, hypertension, neuroleptic malignant syndrome, obesity (What is obesity?), osteoporosis (What is osteoporosis?), renal failure acute, shock. Artane dosage: 4 Mg 1x Per 1 Day. During the same period patient was treated with IMPROMEN (BROMPERIDOL, ) (3 Mg 1x Per 1 Day) (View Impromen (bromperidol, ) Review and Impromen (bromperidol, ) Label ), HALOPERIDOL (4.5 Mg 1x Per 1 Day) (View Haloperidol Review and Haloperidol Label ), VEGETAMIN (View Vegetamin Review and Vegetamin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

4989853-6 | Convulsion
on Apr 21, 2006 Female patient from JAPAN , 71 years of age, was treated with Artane (View Usage). Patient had the following side effects: convulsion. Artane dosage: 4 Mg 1x Per 1 Day Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ).

4979711-5 | Blood Pressure Decreased, Diabetic Ketoacidosis, Heart Rate Increased, Hyperamylasaemia, Ill-defined Disorder, Neuroleptic Malignant Syndrome, Renal Failure Acute
Patient was taking Artane (View Usage). After Artane was administered, patient had the following side effects: blood pressure decreased, diabetic ketoacidosis, heart rate increased, hyperamylasaemia, ill-defined disorder, neuroleptic malignant syndrome, renal failure acute on Apr 06, 2006 from JAPAN Additional patient health information: Female patient , 59 years of age, was diagnosed with schizophrenia and. Artane dosage: 4 Mg 1x Per 1 Day Oral. During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), VIT K CAP (View Vit K Cap Review and Vit K Cap Label ), OSTEN (IPRIFLAVONE) (View Osten (ipriflavone) Review and Osten (ipriflavone) Label ), BLOPRESS (CANDESARTAN CILEXETIL) (View Blopress (candesartan Cilexetil) Review and Blopress (candesartan Cilexetil) Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

4844736-7 | Cardiomyopathy, Haemodialysis, Heart Rate Increased, Neuroleptic Malignant Syndrome, Renal Disorder
Adverse event was reported on Nov 28, 2005 by a Male patient taking Artane (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 54 years of age, Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?), haemodialysis, heart rate increased, neuroleptic malignant syndrome, renal disorder. During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), DROXIDOPA (DROXIDOPA) (View Droxidopa (droxidopa) Review and Droxidopa (droxidopa) Label ), LEVODOPA BENSERAZIDE HYDROCHLO (BENSERAZIDE HYDROCHLORIDE/LEVODOPA) (View Levodopa Benserazide Hydrochlo (benserazide Hydrochloride/levodopa) Review and Levodopa Benserazide Hydrochlo (benserazide Hydrochloride/levodopa) Label ). Patient was hospitalized.

4837284-1 | Condition Aggravated, Incontinence, Neuroleptic Malignant Syndrome, Parkinsonism
on Nov 09, 2005 Male patient from JAPAN , 58 years of age, was diagnosed with parkinsonism and was treated with Artane (View Usage). Patient had the following side effects: condition aggravated, incontinence, neuroleptic malignant syndrome, parkinsonism. Artane dosage: 6 Mg 1x Per 1 Day. During the same period patient was treated with AMANTADINE HCL (100 Mg 1x Per 1 Day) (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA BENSERAZIDE HYDROCHLO (BENSERAZIDE HYDROCHLORIDE/LEVODOPA) (300 Mg 1x Per 1 Day) (View Levodopa Benserazide Hydrochlo (benserazide Hydrochloride/levodopa) Review and Levodopa Benserazide Hydrochlo (benserazide Hydrochloride/levodopa) Label ). Patient was hospitalized.

4820894-5 | Asthma, Confusional State, Difficulty In Walking, Feeling Abnormal, Head Injury, Heart Rate Increased, Hypotonia, Limb Injury
on Nov 04, 2005 Female patient from UNITED STATES , 21 years of age, weighting 232.0 lb, was diagnosed with emotional disorder, schizophrenia and was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: asthma (What is asthma?), confusional state, difficulty in walking, feeling abnormal, head injury, heart rate increased, hypotonia, limb injury. Artane dosage: . During the same period patient was treated with STELAZINE (View Stelazine Review and Stelazine Label ). Patient was hospitalized and became disabled.

4786933-5 | Cardio-respiratory Arrest
Patient was taking Artane (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest on Sep 21, 2005 from UNITED STATES Additional patient health information: Female patient , 45 years of age, . Artane dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ).

4743870-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Gamma-glutamyltransferase Decreased, Hepatic Function Abnormal, Pyrexia
Adverse event was reported on Jul 28, 2005 by a Female patient taking Artane (View Usage) (Dosage: 6 Mg 1x Per 1 Day) was diagnosed with cataplexy and. Location: JAPAN , 36 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, gamma-glutamyltransferase decreased, hepatic function abnormal, pyrexia. During the same period patient was treated with CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), AKINETON (View Akineton Review and Akineton Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

4724378-4 | Coordination Abnormal, Depressed Level Of Consciousness
on Jul 15, 2005 Female patient from JAPAN , child 2 years of age, was treated with Artane (View Usage). After Artane was administered, patient had the following side effects: coordination abnormal, depressed level of consciousness. Artane dosage: Oral. During the same period patient was treated with AKINETON (Oral) (View Akineton Review and Akineton Label ), CARBAMAZEPINE (Oral) (View Carbamazepine Review and Carbamazepine Label ), FLUNITRAZEPAM (FLUNITRAZEPAM, ) (Oral) (View Flunitrazepam (flunitrazepam, ) Review and Flunitrazepam (flunitrazepam, ) Label ), LEVOTOMIN (LEVOMEPROMAZINE MALEATE) (Oral) (View Levotomin (levomepromazine Maleate) Review and Levotomin (levomepromazine Maleate) Label ), PYRETHIA (PROMETHAZINE HYDROCHLORIDE, ) (Oral) (View Pyrethia (promethazine Hydrochloride, ) Review and Pyrethia (promethazine Hydrochloride, ) Label ), RIVOTRIL (CLONAZEPAM, ) (Oral) (View Rivotril (clonazepam, ) Review and Rivotril (clonazepam, ) Label ). Patient was hospitalized.

4711094-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder, Pyrexia
on Jun 29, 2005 Female patient from JAPAN , 36 years of age, was diagnosed with cataplexy and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. Artane dosage: 6 Mg 1x Per 1 Day Oral. During the same period patient was treated with CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), BIPERIDEN (BIPERIDEN) (View Biperiden (biperiden) Review and Biperiden (biperiden) Label ).

4708621-3 | Convulsion, Postictal State
Patient was taking Artane (View Usage). Patient had the following side effects: convulsion, postictal state on Jun 28, 2005 from Additional patient health information: Female patient , 14 years of age, weighting 66.14 lb, . Artane dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), OFLOCET (View Oflocet Review and Oflocet Label ), DEPAKENE (View Depakene Review and Depakene Label ), LIORESAL (View Lioresal Review and Lioresal Label ). Patient was hospitalized.

4707278-5 | Anorexia, Condition Aggravated, Difficulty In Walking, Insomnia, Oedema, Pain, Pigmentation Disorder, Pruritus
Adverse event was reported on Jun 20, 2005 by a Female patient taking Artane (View Usage) (Dosage: 6 Mg 1x Per 1 Day Oral) was diagnosed with tremor and. Location: JAPAN , 45 years of age, After Artane was administered, patient had the following side effects: anorexia, condition aggravated, difficulty in walking, insomnia, oedema, pain (What is pain?), pigmentation disorder, pruritus. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

4597185-3 | Depressed Level Of Consciousness, Rhabdomyolysis
on Feb 15, 2005 Male patient from , 44 years of age, was diagnosed with schizophrenia, nasopharyngitis and was treated with Artane (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, rhabdomyolysis. Artane dosage: 6 Mg 1x Per 1 Day; Oral. During the same period patient was treated with CAFEINE (CAFEINE, ) (View Cafeine (cafeine, ) Review and Cafeine (cafeine, ) Label ), LYSOZYME (LYSOZYME, ) (View Lysozyme (lysozyme, ) Review and Lysozyme (lysozyme, ) Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

4595946-8 | Blood Uric Acid Increased, Depressed Level Of Consciousness, Rhabdomyolysis
on Feb 15, 2005 Male patient from , 44 years of age, was diagnosed with schizophrenia and was treated with Artane (View Usage). Patient had the following side effects: blood uric acid increased, depressed level of consciousness, rhabdomyolysis. Artane dosage: 6 Mg 1x Per 1 Day, Oral. During the same period patient was treated with BUFFERIN (View Bufferin Review and Bufferin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), VEGETAMIN A (CHLORPROMAZINE HYDROCHLORIDE/PHENOBARBITAL/PROMETHAZINE) (View Vegetamin A (chlorpromazine Hydrochloride/phenobarbital/promethazine) Review and Vegetamin A (chlorpromazine Hydrochloride/phenobarbital/promethazine) Label ), ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ). Patient was hospitalized.

4594761-9 | Abdominal Pain, Blood Cortisol Increased, Body Temperature Decreased, Depressed Level Of Consciousness, Diarrhoea, Dyskinesia, Extrapyramidal Disorder, Facial Spasm
Patient was taking Artane (View Usage). After Artane was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood cortisol increased, body temperature decreased, depressed level of consciousness, diarrhoea, dyskinesia, extrapyramidal disorder, facial spasm on Feb 20, 2004 from Additional patient health information: Female patient , 66 years of age, . Artane dosage: . During the same period patient was treated with APROVEL (75 Mg, Qd) (View Aprovel Review and Aprovel Label ), ALDACTAZINE (Unk, Q48h) (View Aldactazine Review and Aldactazine Label ), ISOTEN (5 Mg, Qhs) (View Isoten Review and Isoten Label ), ASAFLOW (160 Mg, Qd) (View Asaflow Review and Asaflow Label ), TRAZOLAN (50 Mg, Qhs) (View Trazolan Review and Trazolan Label ), IMOVANE (3.75 Or 7.5 Mg In The Evening) (View Imovane Review and Imovane Label ), XANAX (.5 Mg, Bid) (View Xanax Review and Xanax Label ). Patient was hospitalized.